Wilkins Investment Counsel’s Eli Lilly LLY Stock Holding History

Wilkins Investment Counsel’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.28M	Sell	2,484 -280	-10%	-$284K	0.33%	58
2025 Q4	$2.97M	Sell	2,764 -78	-3%	-$74.6K	0.43%	49
2025 Q3	$2.17M	Sell	2,842 -36	-1%	-$26.8K	0.31%	54
2025 Q2	$2.24M	Sell	2,878 -310	-10%	-$241K	0.32%	53
2025 Q1	$2.63M	Sell	3,188 -460	-13%	-$383K	0.38%	49
2024 Q4	$2.82M	Buy	3,648 +604	+20%	+$500K	0.41%	50
2024 Q3	$2.7M	Sell	3,044 -60	-2%	-$53.9K	0.37%	52
2024 Q2	$2.81M	Buy	3,104 +240	+8%	+$192K	0.42%	49
2024 Q1	$2.23M	Buy	2,864 +1,886	+193%	+$1.34M	0.33%	55
2023 Q4	$570K	Sell	978 -22	-2%	-$12.8K	0.14%	59
2023 Q3	$537K	Sell	1,000 -370	-27%	-$191K	0.15%	58
2023 Q2	$643K	Sell	1,370 -180	-12%	-$75.5K	0.17%	55
2023 Q1	$532K	Sell	1,550 -100	-6%	-$33.7K	0.14%	59
2022 Q4	$604K	Hold	1,650	–	–	0.16%	59
2022 Q3	$534K	Sell	1,650 -300	-15%	-$95K	0.16%	59
2022 Q2	$632K	Hold	1,950	–	–	0.17%	58
2022 Q1	$558K	Sell	1,950 -100	-5%	-$25.7K	0.13%	64
2021 Q4	$566K	Hold	2,050	–	–	0.12%	63
2021 Q3	$474K	Sell	2,050 -450	-18%	-$111K	0.12%	63
2021 Q2	$574K	Hold	2,500	–	–	0.14%	60
2021 Q1	$467K	Hold	2,500	–	–	0.12%	62
2020 Q4	$422K	Hold	2,500	–	–	0.12%	64
2020 Q3	$370K	Hold	2,500	–	–	0.11%	63
2020 Q2	$410K	Sell	2,500 -100	-4%	-$15.3K	0.13%	63
2020 Q1	$361K	Hold	2,600	–	–	0.13%	63
2019 Q4	$342K	Hold	2,600	–	–	0.1%	70
2019 Q3	$291K	Sell	2,600 -240	-8%	-$26.7K	0.09%	72
2019 Q2	$315K	Hold	2,840	–	–	0.09%	72
2019 Q1	$369K	Hold	2,840	–	–	0.11%	67
2018 Q4	$329K	Hold	2,840	–	–	0.11%	68
2018 Q3	$305K	Hold	2,840	–	–	0.09%	72
2018 Q2	$242K	Hold	2,840	–	–	0.08%	73
2018 Q1	$220K	Hold	2,840	–	–	0.07%	75
2017 Q4	$240K	Hold	2,840	–	–	0.07%	74
2017 Q3	$243K	Hold	2,840	–	–	0.07%	73
2017 Q2	$234K	Hold	2,840	–	–	0.07%	74
2017 Q1	$239K	Hold	2,840	–	–	0.08%	73
2016 Q4	$209K	Sell	2,840 -895	-24%	-$66.7K	0.07%	77
2016 Q3	$300K	Sell	3,735 -5	-0.1%	-$400	0.1%	69
2016 Q2	$295K	Hold	3,740	–	–	0.1%	72
2016 Q1	$269K	Hold	3,740	–	–	0.1%	73
2015 Q4	$315K	Sell	3,740 -1,050	-22%	-$87.1K	0.12%	72
2015 Q3	$401K	Hold	4,790	–	–	0.15%	69
2015 Q2	$400K	Sell	4,790 -350	-7%	-$26.7K	0.15%	68
2015 Q1	$373K	Sell	5,140 -900	-15%	-$64.1K	0.13%	69
2014 Q4	$417K	Sell	6,040 -1,100	-15%	-$74.2K	0.14%	70
2014 Q3	$463K	Hold	7,140	–	–	0.17%	66
2014 Q2	$444K	Hold	7,140	–	–	0.16%	66
2014 Q1	$420K	Sell	7,140 -100	-1%	-$5.58K	0.15%	65
2013 Q4	$369K	Hold	7,240	–	–	0.15%	54
2013 Q3	$364K	Hold	7,240	–	–	0.17%	55
2013 Q2	$356K	Buy	+7,240	New	+$394K	0.17%	53

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wilkins Investment Counsel's LLY Position: Q1 2026 in Review

Wilkins Investment Counsel reduced its Eli Lilly (LLY) stake by 10% in Q1 2026, selling an estimated $284K and leaving 2,484 shares worth $2.28M. The position accounts for 0.33% of the portfolio, ranked #58.

Wilkins Investment Counsel first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.97M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Wilkins Investment Counsel held 2,484 shares of Eli Lilly worth $2.28M as of Q1 2026.
Wilkins Investment Counsel sold 280 Eli Lilly shares in Q1 2026, an estimated $284K.
Eli Lilly made up 0.33% of Wilkins Investment Counsel's portfolio in Q1 2026, its #58 holding.
Wilkins Investment Counsel first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
Wilkins Investment Counsel's Eli Lilly position peaked at $2.97M in Q4 2025.
4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Wilkins Investment Counsel's 13F filing for Q1 2026, filed 7 May 2026.